(Q29616866)

English

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

scientific article (publication date: September 2001)

In more languages

Statements

scholarly article

0 references

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

1 reference

based on heuristic

inferred from title

clinical management

0 references

author name string

Bruix J

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Sherman M

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Beaugrand M

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Lencioni R

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Burroughs AK

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Christensen E

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Pagliaro L

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Colombo M

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Rodés J

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

publication date

September 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Journal of Hepatology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

35

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

421-30

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11592607

30 April 2017

Epidemiology of primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiologic approach for cancer screening. Problems in design and analysis of trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma: US evolution in the early stage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early recognition of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alphafetoprotein: an obituary.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma — a study based on 420 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance status assessment in cancer patients. An inter-observer variability study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatobiliary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma and the art of prognostication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Limits to liver transplantation in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Right lobe living donor liver transplantation: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatic and biliary malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

US-guided percutaneous alcohol injection of small hepatic and abdominal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ablation of liver tumors using percutaneous RF therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Microwave coagulation therapy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials in primary hepatocellular carcinoma: current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29616866&oldid=1795322944"